A spectacular number of celebrities have had their say about Ozempic, Wegovy, and Mounjaro. Here are some examples.

Getting back to “Why Not Stay Fat?” — the title is a philosophical question of impossible scope. Why do anything? It is an existential conundrum.

To change one’s habits is, for most humans, an excruciatingly painful effort, and one not undertaken lightly.

In the course of exorcising personal demons, a terribly difficult and challenging writing experience became a personal case study and a philosophy textbook.

The current topic has morphed from professionals talking with patients to parents talking with children.

Does patient-first language make much of a difference for morbidly obese patients? Let’s take a look.

There is “super morbidly obese” and an additional category called “super super morbidly obese.” Yes, two “supers.”

Research showed that when children are exposed to bullying, body-shaming and negative language, they are at higher risk for developing depressive symptoms.

An ever-increasing number of pros hope to build a better public narrative around childhood obesity, one that avoids knee-jerk victim-blaming.

Given the negative effects of stigma among children with obesity, it is imperative to advocate for PCL use within the medical community.

We’ve been looking at a 2015 paper that explored the pros and cons of policing the language around obesity and how better methods might be implemented.

There is still more to say about the subjects broached in yesterday’s gleanings from a paper titled, “What’s in a Word? On Weight Stigma and Terminology.”

Words can become labels, and labels have a tendency to become stigmatizing.

What causes noncompliance from the patient? Resentment toward authority (the physician, in this case) is not the only obstacle to communication.

People with obesity are accustomed to paying a “fat tax” at clothing stores, and when buying tickets for air travel, and in medical offices.

Some studies show that conscious and unconscious negative attitudes from healthcare professionals impact the treatment and care of people living with obesity.

For quite a few years, Aubrey Gordon was known to the world only as Your Fat Friend. Her first published opinion piece was read by around 40,000 people.

People have all kinds of reasons to pursue weight loss, but then they might discover they have been sold a life-long chemical dependency.

In a large number of cases the new weight-loss medications only work while the person is taking them.

Here is more about the same weight-loss drugs, the ones based on synthetic GLP-1 (glucagon-like peptide-1), that have been referenced in several recent posts.

With weight-loss drugs, the rebound effect is to be expected, and no one should be shocked by the body’s tendency to pile the weight back on again.

The “rebound effect” is brutal. Here are only a few of the many available opinions about that, from diverse sources.

While taking obesity management drugs it is essential to maintain a high level of exercise to not only lose fat but build muscle mass.

Weight-loss drugs are intended to be used along with deliberate diet modification and perpetual exercise, but not everyone wants to hear it.

People might tend to think that if the FDA approves something, then it must be okay. As an antidote to that delusion consider this.

The avoidance of side effects might depend on a person’s shunning of entire categories of food while using tirzepatide.

The semaglutide drugs Ozempic and Wegovy, intended to treat Type 2 diabetes and obesity, respectively, are a risky bet for pregnant people.

In addition to the possibility of hypoglycemia, this drug has been known to cause hair loss, which sounds bad.

The possible side effects of tirzepatide, currently marketed only as Mounjaro, range from embarrassing (like burping) to quite serious.

Soon it might be legal to prescribe Mounjaro (the only medication that contains tirzepatide) to obese young teens.